Comparison of intermittent and continuous proton pump inhibitor infusions in patients with non-variceal upper gastrointestinal bleeding at King Abdulaziz University Hospital, Jeddah, Saudi Arabia

References

1. 1.↵
   1. Laine L,
   2. Laursen SB,
   3. Zakko L,
   4. Dalton HR,
   5. Ngu JH,
   6. Schultz M et al.

   Severity and outcomes of upper gastrointestinal bleeding with bloody Vs. coffee-grounds hematemesis. Am J Gastroenterol 2018; 113: 358–366.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Lanas A,
   2. Dumonceau JM,
   3. Hunt RH,
   4. Fujishiro M,
   5. Scheiman JM,
   6. Gralnek IM et al.

   Nonvariceal upper gastrointestinal bleeding. Nat Rev Dis Primers 2018; 4: 18020.

   OpenUrl
3. 3.↵
   1. Han C,
   2. Ling X,
   3. Liu J,
   4. Lin R and
   5. Ding Z

   . Management of nonvariceal upper gastrointestinal bleeding: role of endoscopic ultrasound-guided treatments. Therap Adv Gastroenterol 2022; 15: 175.

   OpenUrl
4. 4.↵
   1. Alzoubaidi D,
   2. Lovat LB,
   3. Haidry R

   . Management of nonvariceal upper gastrointestinal bleeding: where are we in 2018? Frontline Gastroenterol 2019; 10: 35–42.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Kherad O,
   2. Restellini S,
   3. Martel M,
   4. Barkun A

   . Proton pump inhibitors for upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol 2019; 42-43: 101609.

   OpenUrl
6. 6.↵
   1. Mujtaba S,
   2. Chawla S,
   3. Massaad JF

   . Diagnosis and management of nonvariceal gastrointestinal hemorrhage: a review of current guidelines and future perspectives. J Clin Med 2020; 9: 402.

   OpenUrl
7. 7.↵
   1. Laine L,
   2. Barkun AN,
   3. Saltzman JR,
   4. Martel M,
   5. Leontiadis GI

   . ACG clinical guideline: upper gastrointestinal and ulcer bleeding. Am J Gastroenterol 2021; 116: 899–917.

   OpenUrlPubMed
8. 8.↵
   1. Zhu W,
   2. Chen L,
   3. Zhang J,
   4. Wang P

   . Effects of high-dose versus low-dose proton pump inhibitors for treatment of gastrointestinal ulcer bleeding: a meta-analysis of randomized controlled trials. J Int Med Res 2022; 50: 3000605211067396.

   OpenUrl
9. 9.↵
   1. Sachar H,
   2. Vaidya K,
   3. Laine L

   . Intermittent vs continuous proton pump inhibitor therapy for high-risk bleeding ulcers: a systematic review and meta-analysis. JAMA Intern Med 2014; 174: 1755–1762.

   OpenUrl
10. 10.↵
    1. Worden JC,
    2. Hanna KS

    . Optimizing proton pump inhibitor therapy for treatment of nonvariceal upper gastrointestinal bleeding. Am J Health Syst Pharm 2017; 74: 109–116.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Hajiagha Mohammadi AA,
    2. Reza Azizi M

    . Prognostic factors in patients with active nonvariceal upper gastrointestinal bleeding. Arab J Gastroenterol 2019; 20: 23–27.

    OpenUrl
12. 12.↵
    1. Almadi MA,
    2. Almutairdi A,
    3. Alruzug IM,
    4. Aldarsouny TA,
    5. Semaan T,
    6. Aldaher MK et al.

    Upper gastrointestinal bleeding: Causes and patient outcomes. Saudi J Gastroenterol 2021; 27: 20–27.

    OpenUrl
13. 13.↵
    1. Kim MS,
    2. Moon HS,
    3. Kwon IS,
    4. Park JH,
    5. Kim JS,
    6. Kang SH et al.

    Validation of a new risk score system for nonvariceal upper gastrointestinal bleeding. BMC Gastroenterol 2020; 20: 193.

    OpenUrl
14. 14.↵
    1. Barkun AN,
    2. Almadi M,
    3. Kuipers EJ,
    4. Laine L,
    5. Sung J,
    6. Tse F et al.

    Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the International Consensus Group. Ann Intern Med 2019; 171: 805–822.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Masoodi I,
    2. AlQurashi H,
    3. Al Sofiyani M

    . Changing trends in acute upper GI bleeding a single-centre study in the western region of Saudi Arabia. Br J Medical Pract 2019; 12: a019.

    OpenUrl
16. 16.↵
    1. Leung T,
    2. Kedzior S,
    3. Moore K,
    4. Bierman J,
    5. Coralic Z

    . Intermittent versus continuous infusion dosing of intravenous proton pump inhibitors for upper gastrointestinal bleeding. Ann Pharmacother 2022; 0: 10600280211073936.
17. 17.↵
    1. Mahajan U,
    2. Kapoor D,
    3. Rana BS,
    4. Kumar P,
    5. Kumar D,
    6. Malakar S, et al.

    A study to compare the efficacy of intermittent versus continuous regimen of pantaprazole in the management of upper gastrointestinal bleed (non variceal). Int J Med Sci 2018; 6: 3488.

    OpenUrl
18. 18.↵
    1. Ibrahim E,
    2. Koptan H

    . The effectiveness of standard single dose omeprazole vs. High dose continuous infusion in high-risk critically ill patients. J Anesth Clin Res 2018; 9: 2.

    OpenUrl
19. 19.↵
    1. Khan RS,
    2. Hadi YB,
    3. Chima N,
    4. Kupec J

    . Skipping the drip: intravenous proton pump inhibitor bolus therapy leads to poor outcomes in high-risk bleeding. Cureus 2020; 12: e8362.

    OpenUrl
20. 20.↵
    1. Hsu YC,
    2. Perng CL,
    3. Yang TH,
    4. Wang CS,
    5. Hsu WL,
    6. Wu HT, et al.

    A randomized controlled trial comparing two different dosages of infusional pantoprazole in peptic ulcer bleeding. Br J Clin Pharmacol 2010; 69: 245–251.

    OpenUrlPubMed
21. 21.↵
    1. Neumann I,
    2. Letelier LM,
    3. Rada G,
    4. Claro JC,
    5. Martin J,
    6. Howden CW, et al.

    Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2013: CD007999.
22. 22.↵
    1. Ahmed Al-shargi OY,
    2. Ayesh Mohammed Saghir S,
    3. Al-balagi N,
    4. Hayat A

    . Knowledge assessment of symptoms identification of acute heart attack among staff and students of University Sains Malaysia. Int J Pharm Sci Res 2020; 65: 1–9.

    OpenUrl
23. 23.↵
    1. Yahya Alshargi O,
    2. Mukhlef Alzaid S

    , ibrahim Albahouth Z, Ali Jaber A, Al-Dosari BS. Clinical applications of pharmacometabonomics in neurology: Current status, future perspectives and challenges. Res J Pharm Technol 2022; 15: 976–980.

    OpenUrl